Nivolumab plus chemotherapy or ipilimumab for advanced oesophageal squamous cell carcinoma.

Hindson, Jordan

Hindson, Jordan.

Hindson J; Nature Reviews Gastroenterology & Hepatology, . nrgasthep@nature.com.

Nat Rev Gastroenterol Hepatol ; 19(4): 216, 2022 04.

Article in English | MEDLINE | ID: covidwho-1783991

Subject(s)

Antineoplastic Agents, Immunological; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Antineoplastic Agents, Immunological/therapeutic use; Esophageal Neoplasms/drug therapy; Esophageal Squamous Cell Carcinoma/drug therapy; Humans; Ipilimumab/therapeutic use; Nivolumab/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Esophageal Neoplasms / Antineoplastic Agents, Immunological / Esophageal Squamous Cell Carcinoma Limits: Humans Language: English Journal: Nat Rev Gastroenterol Hepatol Journal subject: Gastroenterology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google